Bon Natural Life Ltd (BON) stock
BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
$1.04−0.03 (-2.80%)
Close on Nov 18, 2026Market cap $8.45MP/E –Yield –
Bon Natural Life operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$1.62M, down 186.6% from the year before. The highest annual figure on record is $6.60M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$1.62M | -186.6% |
| FY2024 | Sep 30, 2024 | $1.87M | -68.4% |
| FY2023 | Sep 30, 2023 | $5.94M | -10.0% |
| FY2022 | Sep 30, 2022 | $6.60M | +22.2% |
| FY2021 | Sep 30, 2021 | $5.40M | +55.7% |
| FY2020 | Sep 30, 2020 | $3.47M | +9.2% |
| FY2019 | Sep 30, 2019 | $3.18M | – |
See a number that looks wrong?